Literature DB >> 10781429

Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia.

J I Aguirre1, N W Morrell, L Long, P Clift, P D Upton, J M Polak, M R Wilkins.   

Abstract

Chronic hypoxia leads to a greater degree of pulmonary hypertension in the Wistar-Kyoto (WKY) rat than in the Fischer 344 (F-344) rat. We questioned whether this difference is associated with baseline differences in pulmonary artery anatomy, a greater degree of hypoxia-induced pulmonary vascular remodeling in the WKY rat, and/or differences in expression of endothelin (ET)-1. Male F-344 and WKY rats were maintained in normoxia or normobaric hypoxia for 21 days. Morphometry revealed that baseline pulmonary artery anatomy was similar in the two strains. However, during chronic hypoxia, the WKY rats developed a greater degree of muscularization of small pulmonary arteries. Baseline plasma and lung immunoreactive ET-1 levels were similar in the WKY and F-344 rats and increased significantly during hypoxia in the WKY rats. Northern analysis demonstrated increased lung preproET-1 mRNA during hypoxia in both strains, with a greater increase in WKY rats. Immunostaining demonstrated increased ET-1 in bronchial epithelium and peripheral pulmonary arteries during hypoxia, although to a greater degree in the WKY rats. We conclude that the WKY strain demonstrates increased susceptibility to hypoxia-induced pulmonary vascular remodeling compared with the F-344 strain and that increased lung and circulating ET-1 levels during hypoxia may partly explain this difference.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781429     DOI: 10.1152/ajplung.2000.278.5.L981

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  12 in total

Review 1.  Structure and composition of pulmonary arteries, capillaries, and veins.

Authors:  Mary I Townsley
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

Review 2.  Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep.

Authors:  Demosthenes G Papamatheakis; Madalitso Chundu; Arlin B Blood; Sean M Wilson
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

3.  Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries.

Authors:  Sergio de Frutos; Juan Manuel Ramiro Diaz; Carlos H Nitta; Mingma L Sherpa; Laura V Gonzalez Bosc
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-27       Impact factor: 4.249

4.  Chronic hypoxia alters fetal cerebrovascular responses to endothelin-1.

Authors:  Jinjutha Silpanisong; Dahlim Kim; James M Williams; Olayemi O Adeoye; Richard B Thorpe; William J Pearce
Journal:  Am J Physiol Cell Physiol       Date:  2017-05-31       Impact factor: 4.249

5.  Mechanisms of NFATc3 activation by increased superoxide and reduced hydrogen peroxide in pulmonary arterial smooth muscle.

Authors:  Juan Manuel Ramiro-Diaz; Wieslawa Giermakowska; John M Weaver; Nikki L Jernigan; Laura V Gonzalez Bosc
Journal:  Am J Physiol Cell Physiol       Date:  2014-08-27       Impact factor: 4.249

Review 6.  Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling.

Authors:  Jinjutha Silpanisong; William J Pearce
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

Review 7.  Antenatal hypoxia and pulmonary vascular function and remodeling.

Authors:  Demosthenes G Papamatheakis; Arlin B Blood; Joon H Kim; Sean M Wilson
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

8.  Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia.

Authors:  Kyan J Allahdadi; Tom W Cherng; Hemanth Pai; Ana Q Silva; Benjimen R Walker; Leif D Nelin; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-30       Impact factor: 4.733

Review 9.  Relevant issues in the pathology and pathobiology of pulmonary hypertension.

Authors:  Rubin M Tuder; Stephen L Archer; Peter Dorfmüller; Serpil C Erzurum; Christophe Guignabert; Evangelos Michelakis; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Nicholas W Morrell
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

10.  Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development.

Authors:  Kristi M Porter; Erik R Walp; Shawn C Elms; Robert Raynor; Patrick O Mitchell; David M Guidot; Roy L Sutliff
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.